ABSTRACT… Objectives: Muscular dystrophies are classified into different types based on their age of onset, clinical severity, rate of progression, distribution of muscles weakness, pattern of inheritance and the genes involved. As muscular dystrophies are relatively uncommon disorders, very little work has been done in Pakistan. This study has classified (for the first time in Pakistan) the patients with different types of muscular dystrophies by clinical and biochemical correlation. Study Design: Observational, descriptive study. Setting:
INTRODUCTION
Muscular dystrophies are classified into different types based on their age of onset, clinical severity, rate of progression, distribution of muscles weakness, pattern of inheritance and the genes involved. 1 The original classification scheme proposed by Walton and Nattrass (1954) 2 included three major groups of muscular dystrophies i-e Duchenne type (Duchenne and Becker), Limbgirdle type, and Fascioscapulohumeral type and there were three comparatively uncommon forms i-e Distal Occulopharyngeal and Congenital type of muscular dystrophies. A significant number of muscle dystrophies are caused by the mutations that affect the normal assembly of the dystrophin and the dystrophin associated glycoprotein complex (DAGC) at the sarcolemma. 3, 4 Diagnosis of a muscular dystrophy usually begins with the clinical suspicion and it has proven to have a very high positive predictive value. On the other hand, the serum creatine phosphokinase (CPK) level is now the single most important blood value to be obtained when myopathy is being considered. Creatine phosphokinase is the enzyme that catalyses the reversible reaction of phosphocreatine and ADP conversion into creatine and ATP and thus involved in the generation of ATP in the muscle cells. Serum CPK is found to be raised in majority of the carriers, as well as in patients, even well before the symptoms appear. Furthermore this might be of help in cases with inconclusive findings on EMG. The increased serum CPK levels in DMD have been attributed to increased creatine kinase released from skeletal muscle fibers judging from the isoform patterns of the enzyme. 5 The increase of CPK is speculated to result from leakage of the enzyme from diseased muscle fibers. 6 The measurement of CPK is an easy, quick, most common, noninvasive test and considered best among the first line investigations for the detection of carriers. 7 Serum aldolase level further helps in suggesting myopathy, because of its longer half-life in serum and it might be raised in setting of myopathy with normal CPK level. 4, 8 Aldolase catalyzes the reversible splitting of fructose 1 :6-diphosphateto glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Diagnostically it is of value in distinguishing primary muscular disease from neurogenic muscular atrophy. The determination is of value in the diagnosis of muscular dystrophy, and in the detection of this condition in children not yet affected clinically. Since the level is raised in affected children, the possibility of using this estimation to detect heterozygous carriers of genes responsible for the various forms of the disease has been considered. The highest levels are seen in the severe sex-linked recessive forms early in the disease (including the stage at which clinical symptoms have not yet appeared). Measurement of LDH M4 isoenzyme helps determine the location and severity of the muscle damage. 9 The levels may be used to monitor acute (as in the case of a traumatic injury) or chronic progressive conditions such as muscular dystrophy.
10 Combined with muscle biopsy and electrophysiology, serum CPK activity is a valuable adjunct; more disease entities were clearly identified and diagnostic accuracy improved.
11 All these criteria, by then refined by much study and scientific discourse, resulted in a classification that included the X-linked Duchenne (DMD) and Becker (Dystrophinopathies), LGMD (sarcoglycanopathies), congenital (laminopathies) and Emery-Dreifuss muscular dystrophy (EDMD), the autosomal dominant facioscapulohumeral (FSHD), distal and oculopharyngeal types, as well as the multisystem disorder, myotonic dystrophy. The names of many of these types clearly indicate the primary diagnostic importance of detailed recording of the distribution of affected muscles; the distinction between DMD and BMD, and between the CMD and LGMD types, depended on the timing and progression of symptoms.
1 Indeed, it was recognized that at least one autosomal dominant form of LGMD existed, although its distinction from BMD or from the Duchenne carrier state, in which proximal muscular weakness sometimes occurs, was a particular problem, and serious errors in the consequent genetic advice were not uncommon. 12, 13 Furthermore, the use of CPK estimation in carriers of the Duchenne dystrophy introduced a useful (though fallible) technique for the scientific study of the carrier state and its genetic implications. The clinical criterion of muscular dystrophies suggested by Pereira (Box-1) was adopted to recruit the patients. Patients with traumatic muscle weakness and/or wasting, with electromyography (EMG) and/or nerve conduction study (NCS) results depicting the neural/neuromuscular origin of the disease were excluded from the study. An informed written consent from the patient or a guardian/ parents of the patient fulfilling the above mentioned clinical criteria was taken. Detailed clinical history and physical examination findings were recorded in predesigned proformas. 
RESULTS
A total of 100 patients including n=77 males and n=23 females were included. Mean age of the total 100 patients was 12.1990 + 6.69913 years (Range = 3.5 -36 years).
All patients reported from different cities and districts from all over Punjab including Okara, Sahiwaal, Sheikhupura, Mureedke, Shadrah, Sargodha, Sialkot, Multan, Gujrat, Jarranwala, Bhawalpur, Bahawalnagar and Wazirabad while majority of patients (46% ; 35% males, 11% females) belonged to Lahore.
The clinical features of these 100 patients are summarized in Table-I Parents of n=76 patients reported with consanguineous marriages. As regards gender, consanguinity was more distributed among females (82.6% vs 74%) (p=0.002). A total of n=31 patients presented with a positive maternal and paternal sided family history of muscular dystrophy in close relatives.
A total of n=87 cases including all males and n=22 (95.7%) females presented with symmetrical muscle involvement (lower limb followed by upper limb). Involvement of the lower limbs as a primary weakness followed by symmetrical and severe involvement of the upper limb girdle and lower limb girdle suggested LGMD in 9 (6F,3M) patients. Involvement of shoulders and upper limbs as a primary weakness followed by facial muscles and infrequent involvement of lower limbs suggested FSHMD in 2 cases. Involvement of upper limbs as a primary weakness followed by lower limbs with a moderate rise in CPK levels and mild phenotype was seen in two female patient which was quite suggestive of dysferlinopathy. 
DISCUSSION
Duchenne muscular dystrophy, the most common form of muscular dystrophy in children, is an X-linked, severe and progressive muscular dystrophy with a birth prevalence of 1 in 3500 live born males. 4, 15 The milder Becker Muscular Dystrophy (BMD), a variant of DMD, shows a less severe but more variable phenotype, ranging from a slightly less severe DMD-like condition to a very mild condition. Overall, the physical picture of BMD patients resembles with that of DMD. The main difference with DMD is in the age of onset (later for BMD) and rate of progression. 16, 17 The prevalence of BMD at birth is 1 in 8500 live born males. In contrast to DMD they show more heterogeneous profile, clinical phenotypes and the morphological changes vary greatly.
18
In the present study, mild-moderate phenotype that related significantly to serum CPK levels classified the patients as BMD based on their later age of onset. Rest 74 cases with moderatesevere phenotype and very high CPK levels were classified as of having DMD. The limb girdle muscular dystrophies are classically defined as muscular dystrophies that involve proximal upper and lower limbs muscles predominantly. Some features in LGMD which could be found in addition to typical proximal weakness include scapular winging, dysarthria, contractures, scoliosis and distal muscle involvement. In the present study, 9 patients (6F, 3M) presented with the typical clinical pattern suggestive of LGMD. One male and 3 females were partial ambulatory with moderate phenotype and involvement of upper limb girdle. The other 3 female and 2 male patients were non ambulatory with severe phenotype and lower limb girdle involvement. Involvement of girdles, however, was observed not as a primary manifestation but following the significant motor weakness of the limbs.
LGMD was first described as a clinical entity by Watson and Nattrass (1954). They are termed as such, as they share the characteristic features of muscle weakness predominantly affecting the shoulder and pelvic girdle. The LGMD are broadly divided into two i-e autosomal dominant (designated LGMD2) and autosomal recessive (LGMD1), and these two are now further subdivided into 19 subtypes on the basis of the clinical diversity and genetic mutations found in them 2, 19 A few of the recessive forms have been linked to the mutations in proteins that constitute the dystrophin-glycoprotein complex. 20 Mutations in dysferlin, a protein that is thought to interact with Caveolin 3, cause LGMD2B. 21, 22 Dysferlin is the protein product of the 2p13 gene and is normally localized to the muscle plasma membrane. Two female patients in the present study presented with predominant upper limb involvement with girdle sparing and milder phenotype with no respiratory and cardiac muscles involvement, which is consistent with the reports from other authors 22, 23, 24 and hence classified as a patient with dysferlinopathy.
Facioscapulohumeral muscular dystrophy is a progressive degenerative disease that initially affects the muscles of the face, shoulders, and upper arms followed by the muscles of the feet, pelvic girdle, and abdomen. Affected individuals may also suffer from hearing loss. Onset and progression of the disease is variable and often the weakness is asymmetrical in affected individuals. 25 The essential clinical features are weakness of facial muscles, scapulohumeral, tibialis anterior and pelvic girdle muscle involvement which was the feature seen in the present study in one male patient, 11 years of age having moderate to severe phenotype. Many patients are only mildly affected as the other patient, 27 years male, diagnosed of having FSHMD in the present study. 26 CMDs associated with the deficiency of Laminin alpha-2 and collagen-VI are the commonest subtypes in many countries especially of European origin.
27
Congenital muscular dystrophy is comparatively infrequent autosomal recessive form of dystrophy existing at birth or in initial infancy with hypotonia, generalized weakness and contractures as the presenting symptoms. With only authentic report of 0.68 to 2.5 per 100,000 point prevalence by Peat et al (2008) . 28 Inability to diagnosis of primary muscle weakness with and without intellectual debility may have led to a continued underestimation of its prevalence. 29, 30 Furthermore, the comparative frequency of CMD subtypes differs in different populations. 31 The important differential diagnosis in this context is the cLGMD that can have its onset at childhood, even if symptoms appear more frequently in adolescence or young adulthood. 20 The present study reports one male patient, 3 years of age with onset of weakness at 6 months, who presented with a progressive muscle weakness leading to a moderate phenotype with dysmorphic facies, jaw weakness and COPD at the time of presentation. Cranial MRI suggested white matter changes. The other male patient, 5 years of age with onset of limb weakness in perinatal period, presented with a severe phenotype including jaw weakness and associated COPD. No mass lesion on CT Scan or evidence of intellectual impairment was seen which was consistent with the findings reported by Mercuri et al. 30 Since early 20 th century, the diagnosis of muscle dystrophies is aided by the very significant laboratory assistance provided by serum CPK estimations, an invaluable test pioneered by Hideo Sugita and Setsuro Ebashi. 32 Warburg and Christian (1943) reported incidental finding of raised serum aldolase in case of muscular dystrophies. Later on it was also confirmed by Sibley and Fleisher (1954) who later on also found that the enzyme was not raised in other neuromuscular diseases. 33, 34 The patients in the present study also demonstrated at least 10-150 times raised enzyme levels that related significantly with the severity of disease.
Females may be the obligate carriers i-e a woman with at least one affected son and one affected male member or with two or more affected sons. They can be possible carriers i-e mothers of isolated case of muscular dystrophy, would be a manifesting/ symptomatic carrier when she is a female with positive family history in males, raised serum creatine phosphokinase (CPK) and some proximal muscle weakness. 7 In present study, 4 of 23 female patients presented with very milde phenotype with mildly raised CPK levels that depicted carrier status in them. A. Substantial contribution to conception or design of the work; or the acquisition, analysis or interpretaion of data for the work. B. Drafting of the work or revising it critically for important intellectual content. C. Final approval of the version to be puslished. B. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work and appropriately investigated and resolved.
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